Mi
Mirati (BMS)
San Diego CAFounded 2012800 employees
Private CapbiotechAcquiredOncology
Platform: KRAS Inh
Market Cap
N/A
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| MIR-8648 | MIR-8648 | Phase 1/2 | 1 | GLP-1R | ThymomaEwing Sarcoma | ||
| MIR-7357 | MIR-7357 | Preclinical | 1 | USP1 | Gastric CaAngelman |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (2)